Research Paper Volume 16, Issue 10 pp 8944—8964
SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer
Figure 16. Representative immunohistochemical staining of SLAMF8 in HCC, PRAD and KIRC tissues. (A) Positive expression of SLAMF8 in HCC tissue, Magnification ×100. (B) Positive expression of SLAMF8 in HCC tissue, Magnification ×400. (C) Positive expression of SLAMF8 in PRAD tissue, Magnification ×100. (D) Positive expression of SLAMF8 in PRAD tissue, Magnification ×400. (E) Positive expression of SLAMF8 in KIRC tissue, Magnification ×100. (F) Positive expression of SLAMF8 in KIRC tissue, Magnification ×400. (G–I) Different expression of SLAMF8 in HCC, PRAD, KIRC tissue and matched adjacent noncancerous tissues. *P < 0.05, **P < 0.01, ***P < 0.001.